Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Fiche publication
Date publication
avril 2019
Journal
Journal of cachexia, sarcopenia and muscle
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier, Dr FOUCHER Pascal
Tous les auteurs :
Antoun S, Morel H, Souquet PJ, Surmont V, Planchard D, Bonnetain F, Foucher P, Egenod T, Krakowski I, Gaudin H, Debieuvre D
Lien Pubmed
Résumé
An international consensus proposed in 2011 a definition and classification system for cachexia (CAX), mainly based on weight loss, sarcopenia [skeletal muscle mass (SMM) loss], inflammation, and anorexia. The aim of this study was to stage CAX in non-small-cell lung cancer (NSCLC) patients by using a classification based on the Fearon criteria and supported by quantifiable parameters.
Référence
J Cachexia Sarcopenia Muscle. 2019 Apr 1;: